Issue 2 • March 2017

Earlier Detection Means an Earlier Cure

Data from the US National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program, charted below, illustrates the critical importance of early cancer detection.



Earlier diagnosis is one of the foremost objectives of cancer medicine for the simple reason that it saves lives.

Detecting Small Tumors

Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly.  So, to find cancers at the earlier stages when they can be treated more effectively, clinicians must have the ability to detect smaller tumors. That's why Imagion Biosystems is working hard to develop MagSense™ superparamagnetic relaxometry (SPMR) technology.

The chart below illustrates the theoretical relative limits of detection of SPMR vs conventional imaging methods (CT and MRI):
Graphic reproduction courtesy of MD Anderson Cancer Center Dept. of Imaging Physics
We believe that MagSense technology could have the ability to accurately detect a roughly spherical tumor of approximately one millimeter diameter. Relative to conventional imaging methods, this could allow diagnosis to occur significantly earlier. And save lives.

Recent Progress Published

Scientists at Imagion Biosystems, along with our collaborators, continue to push back the boundaries of detection limits in our quest to improve on the early detection of cancer. Our recent research study, "Development of advanced signal processing and source imaging methods for superparamagnetic relaxometry," published January 10th in the journal Physics in Medicine and Biology, describes their improvements in the way magnetic field signals arising from superparamagnetic relaxation are collected and interpreted to yield information about the quantity and location of nanoparticles bound to cancer cells. This research will enable the development of cancer detection systems that are more accurate, more sensitive, and simpler to use.

Read Development of advanced signal processing and source imaging methods for superparamagnetic relaxometry at IOP Publishing.
IN THIS ISSUE:
Earlier Cancer Detection
Detecting Small Tumors
New R&D Publication
Visit Our New Website
Order PrecisionMRX® Nanoparticles Here
Size Matters – at least for nanoparticles. Click here to learn more.
CONTACT US
Our mailing address is:
Imagion Biosystems
10355 Science Center Drive
Suite 210
San Diego, CA 92121

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list
Copyright © 2017 Imagion Biosystems, All rights reserved.
 You are receiving this email because you have requested information about Imagion Biosystems (formerly Senior Scientific).
View this email in your browser

  Not a subscriber? Sign up here!